{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:10:50Z","timestamp":1790665850065,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T00:00:00Z","timestamp":1424217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1038-y","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T06:50:54Z","timestamp":1424155854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans"],"prefix":"10.1186","volume":"15","author":[{"given":"Sherrie L","family":"Aspinall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester B","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca E","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette B","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida","family":"Passero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roslyn A","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Sartore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Patrick","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Giberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolynn","family":"Sessions","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Depcinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Fishco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irvin","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Lepir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lymaris","family":"Cruz-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Calderon-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Maland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Tague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Glovack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Cosgriff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Kaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Tonnu-Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkamal","family":"Chatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,18]]},"reference":[{"key":"1038_CR1","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines Version 3.2014. Colon Cancer. [ http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp ]"},{"key":"1038_CR2","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343\u201351.","journal-title":"N Engl J Med"},{"key":"1038_CR3","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","volume":"27","author":"T Andr\u00e9","year":"2009","unstructured":"Andr\u00e9 T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in MOSAIC trial. J Clin Oncol. 2009;27:3109\u201316.","journal-title":"J Clin Oncol"},{"key":"1038_CR4","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","volume":"29","author":"DG Haller","year":"2011","unstructured":"Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol. 2011;29:1465\u201371.","journal-title":"J Clin Oncol"},{"key":"1038_CR5","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1200\/JCO.2011.41.1140","volume":"30","author":"HK Sanoff","year":"2012","unstructured":"Sanoff HK, Carpenter WR, Sturmer T, Goldberg RM, Martin CF, Fine JP, et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012;30:2624\u201334.","journal-title":"J Clin Oncol"},{"key":"1038_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jgo.2012.12.004","volume":"4","author":"J Hermosillo-Rodriguez","year":"2013","unstructured":"Hermosillo-Rodriguez J, Anaya DA, Sada Y, Walder A, Amspoker AB, Berger DH, et al. The effect of age and comorbidity on patient-centered health outcomes in patients receiving adjuvant chemotherapy for colon cancer. J Geriatr Oncol. 2013;4:99\u2013106.","journal-title":"J Geriatr Oncol"},{"key":"1038_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.2011.35.0058","volume":"29","author":"TA Abrams","year":"2011","unstructured":"Abrams TA, Brightly R, Mao J, Kirkner J, Meyerhardt JA, Schrag D, et al. Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer. J Clin Oncol. 2011;29:1\u20138.","journal-title":"J Clin Oncol"},{"key":"1038_CR8","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1200\/JCO.2005.04.5005","volume":"24","author":"AI Neugut","year":"2006","unstructured":"Neugut AI, Matasar M, Wang X, McBride R, Jacobson JS, Tsai WY, et al. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol. 2006;24:2368\u201375.","journal-title":"J Clin Oncol"},{"key":"1038_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/sj.bjc.6603627","volume":"96","author":"M Morris","year":"2007","unstructured":"Morris M, Platell C, Fritschi L, Iacopetta B. Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients. Brit J Can. 2007;96:701\u20137.","journal-title":"Brit J Can"},{"issue":"Suppl 15","key":"1038_CR10","doi-asserted-by":"crossref","first-page":"abstract 3624","DOI":"10.1200\/jco.2010.28.15_suppl.3624","volume":"28","author":"J Ho","year":"2010","unstructured":"Ho J, Gill S, Woods R, Kennecke HF. Association of survival outcomes with dose intensity of adjuvant therapy with capecitabine for colorectal cancer. J Clin Oncol. 2010;28 Suppl 15:abstract 3624.","journal-title":"J Clin Oncol"},{"key":"1038_CR11","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s12032-010-9644-7","volume":"28","author":"CY Hu","year":"2011","unstructured":"Hu CY, Delclos GL, Chan W, Du XL. Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage III colon cancer. Med Oncol. 2011;28:1062\u201374.","journal-title":"Med Oncol"},{"key":"1038_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3656-4","volume-title":"American Joint Committee on Cancer (AJCC). Cancer Staging Manual (ed 6)","author":"FL Greene","year":"2002","unstructured":"Greene FL, Page DL, Flemming ID, Fritz AG, Balch CM, Haller DG, et al. American Joint Committee on Cancer (AJCC). Cancer Staging Manual (ed 6). New York: Springer-Verlag; 2002."},{"key":"1038_CR13","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1001\/jama.2011.749","volume":"305","author":"JJ Biagi","year":"2011","unstructured":"Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant and survival in colorectal cancer. JAMA. 2011;305:2335\u201342.","journal-title":"JAMA"},{"key":"1038_CR14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.5858\/2000-124-0979-PFICC","volume":"124","author":"CC Compton","year":"2000","unstructured":"Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors on colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:979\u201394.","journal-title":"Arch Pathol Lab Med"},{"key":"1038_CR15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.1984.2.11.1281","volume":"2","author":"W Hryniuk","year":"1984","unstructured":"Hryniuk W, Bush H. The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol. 1984;2:1281\u20138.","journal-title":"J Clin Oncol"},{"key":"1038_CR16","doi-asserted-by":"publisher","first-page":"8664","DOI":"10.1200\/JCO.2005.01.6071","volume":"23","author":"DJ Sargent","year":"2005","unstructured":"Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2005;23:8664\u201370.","journal-title":"J Clin Oncol"},{"key":"1038_CR17","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1200\/JCO.2006.10.4323","volume":"25","author":"DJ Sargent","year":"2007","unstructured":"Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, Benedetti J, et al. End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT group. J Clin Oncol. 2007;25:4569\u201374.","journal-title":"J Clin Oncol"},{"key":"1038_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"Suppl 1","key":"1038_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2147\/CLEP.S47150","volume":"5","author":"M S\u00f8gaard","year":"2013","unstructured":"S\u00f8gaard M, Thomsen RW, Bossen KS, S\u00f8rensen HT, N\u00f8rgaard M. The impact of comorbidity on cancer survival: a review. Clin Epidem. 2013;5 Suppl 1:3\u201329.","journal-title":"Clin Epidem"},{"key":"1038_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1200\/JCO.2012.44.4711","volume":"31","author":"CJ Allegra","year":"2013","unstructured":"Allegra CJ, Yothers G, O\u2019Connell MJ, Sharif S, Petrelli NJ, Lopa SH, et al. Bevacizumab in stage II-III colon cancer: 5-year update of the national surgical adjuvant breast and bowel project C-08 trial. J Clin Oncol. 2013;31:359\u201364.","journal-title":"J Clin Oncol"},{"key":"1038_CR21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1470-2045(12)70509-0","volume":"13","author":"A Gramont De","year":"2012","unstructured":"De Gramont A, Van Cutsem E, Schmoll HJ, Tabernero J, Clarke S, Moore MJ, et al. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial. Lancet Oncol. 2012;13:1225\u201333.","journal-title":"Lancet Oncol"},{"key":"1038_CR22","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/1097-0142(19900915)66:6<1124::AID-CNCR2820660608>3.0.CO;2-T","volume":"66","author":"R Epelbaum","year":"1990","unstructured":"Epelbaum R, Faraggi D, Ben-Arie Y, Ben-Shahar M, Haim N, Robinson E, et al. Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables. Cancer. 1990;66:1124\u20139.","journal-title":"Cancer"},{"key":"1038_CR23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.annonc.a058619","volume":"4","author":"E Lepage","year":"1993","unstructured":"Lepage E, Gisselbrecht C, Haioun C, Sebban C, Tilly H, Bosly A, et al. Prognostic significance of received relative dose intensity in non-Hodgkin\u2019s lymphoma patients: application to LNH-87 protocol. The GELA. Ann Oncol. 1993;4:651\u20136.","journal-title":"Ann Oncol"},{"key":"1038_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/1078155211436022","volume":"18","author":"D Bhattacharya","year":"2012","unstructured":"Bhattacharya D, Easthall C, Willoughby KA, Small M, Watson S. Capecitabine non-adherence: exploration of magnitude, nature and contributing factors. J Oncol Pharm Pract. 2012;18:333\u201342.","journal-title":"J Oncol Pharm Pract"},{"key":"1038_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000328317","volume":"80","author":"R Winterhalder","year":"2011","unstructured":"Winterhalder R, Hoesli P, Demore G, Pederiva S, Bressoud A, Hermann F, et al. Self-reported compliance with capecitabine: findings from a prospective cohort analysis. Oncology. 2011;80:29\u201333.","journal-title":"Oncology"},{"key":"1038_CR26","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1001\/jama.294.21.2703","volume":"294","author":"JM Jessup","year":"2005","unstructured":"Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer. Implications of race\/ethnicity, age and differentiation. JAMA. 2005;294:2703\u201311.","journal-title":"JAMA"},{"key":"1038_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/DCR.0b013e3181974384","volume":"52","author":"LH Iversen","year":"2009","unstructured":"Iversen LH, Norgaard M, Jacobsen J, Laurberg S, Sorensen HT. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995\u20132006 \u2013 a population-based cohort study. Dis Colon Rectum. 2009;52:71\u20138.","journal-title":"Dis Colon Rectum"},{"key":"1038_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2407-9-116","volume":"9","author":"D Sarfati","year":"2009","unstructured":"Sarfati D, Hill S, Blakely T, Robson B, Purdie G, Dennett E, et al. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer. 2009;9:116.","journal-title":"BMC Cancer"},{"key":"1038_CR29","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1200\/JCO.2013.49.6489","volume":"31","author":"AA Aizer","year":"2013","unstructured":"Aizer AA, Chen MH, McCarthy EP, Mendu ML, Koo S, Wilhite TJ, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31:3869\u201376.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1038-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1038-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T21:49:43Z","timestamp":1651268983000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1038-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,18]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1038-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,18]]},"article-number":"62"}}